companydata.dkcompanydata.dk

MEDIDYNE A/S: Financial statements 2022

CVR: 26925398

Source: annual report 2022, Danish Business Authority

01/04/2021 – 31/03/2022

MEDIDYNE A/S (CVR 26925398) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 53,372,967 and a net result of DKK 15,192,849 compared with DKK 24,245,923 the year before. That is a decrease of 1.5% compared with the year before. Equity in the 2022 report amounted to DKK 42,058,066. The solvency ratio was 49.1%. The company had 30 employees in the financial year.

Gross Profit
DKK 53,372,967
Profit/Loss
DKK 15,192,849
Equity
DKK 42,058,066
Total Assets
DKK 85,576,824
Employees
30

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-53.4M15.2M42.1M30
2021-54.2M24.2M48.2M32
2020-35.1M8.8M33.4M30
2019-26.6M2M24.6M-
2018-17M4.7M22M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on MEDIDYNE A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About MEDIDYNE A/S

MEDIDYNE A/S is a Danish company of the type Aktieselskab based in Nærum, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MEDIDYNE ApS and MEDIDANE HJERTEVAGT ApS. The management consists of Knut Werring Clem. The board consists of Frederik Werring Clem (chair), Knut Werring Clem and Søren Stenkilsson. The company is owned by HJERTEVAGT HOLDING ApS. The company has 54 employees (2026). In 2026, the company reported a gross profit of DKK 58,462,605 and a net result of DKK 18,130,205 compared with DKK 10,977,494 the year before.

Source: annual report 2026, Danish Business Authority